I accept that my opinion is controversial and may be wrong, but I think the technical picture is very weak and the fundamentals of the company are experimental rather than proven to treat the diseases in question. The rally looks to be stalling. Does anybody understand the science that can explain to me why I should be a buyer? Was there anything important/unknown to the market at the goldman sachs conference?
Mesoblasted, page-26
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.5¢ |
Change
0.020(2.19%) |
Mkt cap ! $1.064B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 94.5¢ | 92.0¢ | $1.493M | 1.604M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 179047 | 93.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.5¢ | 4876 | 2 |
View Market Depth
| Last trade - 15.41pm 11/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |